A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-17.14%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$292M
AUM Growth
+$292M
Cap. Flow
-$75.7M
Cap. Flow %
-25.91%
Top 10 Hldgs %
98.38%
Holding
18
New
1
Increased
–
Reduced
1
Closed
3

Top Buys

No buys this quarter

Top Sells

1
PSNL icon
Personalis
PSNL
$96.7M
2
CRSP icon
CRISPR Therapeutics
CRSP
$21.7M
3
TARA icon
Protara Therapeutics
TARA
$344K
4
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$86.4K

Sector Composition

1 Healthcare 85.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$111M 37.88%
4,168,718
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$40M 13.67%
1,203,135
– –
SLNO icon
3
Soleno Therapeutics
SLNO
$3.6B
$19.9M 6.8%
10,302,602
– –
VRNA
4
Verona Pharma
VRNA
$9.16B
$16.9M 5.79%
2,457,499
– –
NCNA
5
NuCana
NCNA
$6.09M
$15M 5.12%
3,333,333
– –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$13.9M 4.76%
871,125
-5,416
-0.6% -$86.4K
XCUR icon
7
Exicure
XCUR
$35.4M
$12.3M 4.22%
6,977,000
– –
SIEN
8
DELISTED
Sientra, Inc.
SIEN
$9.3M 3.18%
2,390,843
– –
PRTK
9
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.52M 2.23%
1,041,131
– –
SYRE icon
10
Spyre Therapeutics
SYRE
$996M
$1.89M 0.65%
240,500
– –
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
$1.88M 0.64%
200,000
– –
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
$752K 0.26%
131,036
– –
OBSV
13
DELISTED
ObsEva SA Ordinary Shares
OBSV
$182K 0.06%
87,999
– –
OCGN icon
14
Ocugen
OCGN
$319M
$13K ﹤0.01%
7,111
– –
CRSP icon
15
CRISPR Therapeutics
CRSP
$4.71B
– –
-259,599
Closed -$21.7M
PSNL icon
16
Personalis
PSNL
$434M
– –
-4,462,452
Closed -$96.7M
TARA icon
17
Protara Therapeutics
TARA
$120M
– –
-20,610
Closed -$344K